TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
MIRAPHARM AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
16
|
13
|
10 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
5
|
3
|
403 |
| EBITDA |
0
|
-1
|
2 |
| Total assets |
138
|
185
|
413 |
| Current assets |
109
|
155
|
383 |
| Current liabilities |
3
|
5
|
2 |
| Equity capital |
135
|
180
|
411 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
0 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
97.8%
|
97.3%
|
99.5% |
| Turnover per employee |
16
|
13 | |
| Profit as a percentage of turnover |
31.2%
|
23.1%
|
4030.0% |
| Return on assets (ROA) |
3.6%
|
1.6%
|
97.6% |
| Current ratio |
3633.3%
|
3100%
|
19150.0% |
| Return on equity (ROE) |
3.7%
|
1.7%
|
98.1% |
| Change turnover |
3
|
3
|
1 |
| Change turnover % |
25%
|
30%
|
14% |
| Chg. No. of employees |
0
|
1
|
0 |
| Chg. No. of employees % | 0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.